Hepatitis Vaccination and Prevention Strategies in Indonesia

Hepatitis remains one of Indonesia’s most serious public health challenges, particularly hepatitis B, a viral infection that attacks the liver and can cause both short-term and long-term illness. Over the years, Indonesia has made remarkable progress in reducing hepatitis B infections through vaccination and better healthcare access.

Still, the fight continues, as millions of Indonesians live with hepatitis B, and new infections are reported every year. At Bali International Hospital, we believe that prevention is the best protection.

Through vaccination, education, and early detection, we aim to help our community stay safe and healthy.

Hepatitis B and Its Impact

Hepatitis B is caused by the hepatitis B virus (HBV). It spreads when an uninfected person comes into contact with the blood or body fluids of someone who carries the virus.

This can happen through mother-to-child transmission during childbirth, unsafe injections, or unprotected sexual contact. Chronic hepatitis B can cause serious liver damage over time, leading to cirrhosis or liver cancer, both of which can be life-threatening.

In Indonesia, hepatitis B has long been a major health issue. According to the Ministry of Health, the national prevalence dropped from 7.1% in 2013 to 2.4% in 2023, thanks to the success of vaccination programs and stronger public awareness.

However, an estimated 6.7 million Indonesians are still living with hepatitis B, and more than 60,000 deaths in 2023 were linked to hepatitis-related complications.

Indonesia’s National Hepatitis B Vaccination Program

Indonesia began its national hepatitis B vaccination program in 1997, focusing on infants as the priority group. The vaccination schedule includes a birth dose given within 24 hours after birth, followed by additional doses during infancy.

This approach has shown clear results; birth dose coverage has reached 83.1%, which has helped reduce new infections significantly. However, coverage for the subsequent doses drops to around 60%, indicating the need for stronger follow-up and community education.

At our international hospital, we fully support Indonesia’s immunization goals. We encourage parents to complete the entire hepatitis B vaccination schedule for their children, as full protection requires all doses.

Key Prevention Strategies in Indonesia

To achieve the national target of hepatitis elimination by 2030, Indonesia continues to strengthen its prevention strategies. These go beyond just childhood immunization and include several key initiatives:

1. Universal Newborn Immunization

Every newborn in Indonesia should receive the hepatitis B vaccine within 24 hours of birth. This early protection is crucial to prevent mother-to-child transmission, which remains one of the most common infection routes.

2. Screening for Pregnant Women

Routine hepatitis B screening for pregnant women helps identify those who carry the virus (HBsAg-positive). When necessary, antiviral medication such as Tenofovir can be prescribed during pregnancy to lower the risk of passing the virus to the baby.

3. Vaccination for Healthcare Workers and High-Risk Groups

Healthcare professionals, laboratory staff, and individuals frequently exposed to blood or body fluids are at higher risk of infection. Vaccination for healthcare workers and other high-risk adults is a key preventive step to protect both the individual and the patients they care for.

4. Public Awareness and Education

Education plays an important role in reducing hepatitis transmission. Through public campaigns, communities learn how hepatitis spreads and how vaccination can prevent it.

Increased awareness also helps reduce stigma toward people living with hepatitis.

5. Expanding Access to Healthcare

To ensure equitable healthcare, Indonesia continues to improve access to vaccination and testing, especially in rural and remote areas. Tackling economic and social barriers is vital to ensure everyone has the chance to get vaccinated and receive timely care.

6. Early Diagnosis and Treatment

For people already infected with hepatitis B, early diagnosis and antiviral treatment are crucial in preventing serious liver disease. Providing affordable treatment and regular monitoring helps improve long-term health outcomes and reduces the spread of infection.

Challenges and Emerging Concerns

Although Indonesia has made great strides, several challenges remain. Incomplete vaccination schedules among infants could lead to new infections in the future.

Additionally, recent reports of acute hepatitis of unknown cause in children serve as reminders that continued research and monitoring are needed. Social and cultural factors can also influence vaccination rates.

Misconceptions, lack of access, or financial barriers may discourage people from seeking vaccination or testing. These challenges require collaboration between hospitals, government agencies, and community leaders to ensure that no one is left behind.

How Our Hospital Supports Hepatitis Prevention

At Bali International Hospital, we actively contribute to Indonesia’s national goal of hepatitis elimination through comprehensive medical services and awareness initiatives. Our efforts include:

• Complete hepatitis vaccination programs for children, adults, and healthcare workers
• Maternal screening and management for hepatitis B during pregnancy
• Safe and effective antiviral treatments for hepatitis-positive patients
• Public health education to spread accurate information and reduce stigma
• Laboratory testing and early detection for better disease management

Our multidisciplinary team ensures that every patient receives personalized, compassionate, and evidence-based care. Whether you need vaccination, screening, or treatment, we are here to guide you every step of the way.

Frequently Asked Questions

Are Hepatitis A and B vaccines mandatory?

The Hepatitis A vaccine isn’t mandatory but is recommended for travelers and those at risk. The Hepatitis B vaccine is part of Indonesia’s national immunization program for newborns, making it required for infants.

For adults, it’s recommended for healthcare workers and high-risk groups, but not mandatory.

Is a three-dose hepatitis vaccine mandatory?

The Hepatitis B vaccine requires three doses. This full series is mandatory for infants under the national program but voluntary for adults, though strongly advised.

When is the hepatitis vaccine given?

Newborns receive the first Hepatitis B dose within 24 hours of birth, followed by two doses in infancy. Adults who begin vaccination also complete three doses several months apart.

The Hepatitis A vaccine is usually two doses, given 6-12 months apart for those at risk.

What are the preventive measures for hepatitis?

Key prevention methods include:

• Timely newborn vaccination
• Screening pregnant women
• Vaccinating healthcare workers
• Practicing safe injections
• Improving hygiene
• Ensuring clean food and water
• Promoting public awareness

Get the Right Care at Our International Hospital

Protect yourself and your loved ones from hepatitis by staying informed and getting vaccinated. If you’re unsure about your vaccination status or need testing, book an appointment or contact us to speak with our medical specialists today.

At our hospital, our Hepatology Center in Bali provides comprehensive liver care, from hepatitis screening and treatment to complete vaccination programs. We offer a Hepatitis B Vaccine Package for infants and adults, as well as an Adult Hepatitis A Vaccine Package for those who need additional protection, especially frequent travelers or individuals at higher risk.

Your health and safety are our top priorities. Together, let’s take the next step toward a hepatitis-free Indonesia.